Raynaud syndrome, often called Raynaud's phenomenon, is a condition in which brief episodes of vasospasm in small arteries and arterioles cause transient reduction of blood flow to the extremities. Episodes typically affect the fingers and toes and sometimes the ears, nose or lips. The attacks are most commonly provoked by cold exposure or emotional stress and usually resolve with rewarming or relaxation.

Typical features and course

Most attacks proceed through a characteristic sequence of color and sensation changes: pallor (white) from arterial constriction, cyanosis (blue) as oxygen is depleted, and reactive hyperemia (red) when blood flow returns. Symptoms include numbness, tingling, pain, and a feeling of cold in the affected parts. Attacks may last from minutes to hours; frequent or prolonged episodes can increase the risk of skin breakdown.

Types and causes

Clinically Raynaud is divided into primary (idiopathic) and secondary forms. Primary Raynaud disease has no identifiable underlying disorder and is generally less severe. Secondary Raynaud phenomenon occurs in association with other conditions—most notably systemic connective tissue diseases such as systemic sclerosis (scleroderma), lupus or rheumatoid arthritis—or with occupational exposures (vibration), vascular disease, certain medications, or trauma. Identifying secondary causes is important because they can lead to complications.

Diagnosis and evaluation

Diagnosis is based on the history, typical triggers and the pattern of color changes. Physical examination between attacks is often normal in primary Raynaud. When a secondary cause is suspected, clinicians may order tests such as nailfold capillary microscopy, autoimmune serologies, or vascular studies to look for underlying connective tissue disease or structural vascular problems.

Management and prevention

Treatment aims to prevent attacks, relieve symptoms and protect tissue. General measures include avoiding cold, wearing insulating gloves and layered clothing, smoking cessation and stress reduction. Medication options for frequent or severe episodes include vasodilators such as calcium channel blockers (e.g., nifedipine), topical nitrates, phosphodiesterase inhibitors, or prostaglandin infusions in refractory cases. In rare, severe situations with ischemic ulcers or gangrene, surgical sympathectomy or vascular interventions may be considered.

Importance and prognosis

Primary Raynaud often has a benign course and may be managed by lifestyle measures alone. Secondary Raynaud can signal a systemic disease and carries a higher risk of complications like digital ulcers or tissue loss, so timely assessment for underlying disorders is important. Patient education about trigger avoidance and early treatment of prolonged attacks reduces the risk of long-term damage.

  • Common triggers: cold exposure, emotional stress, nicotine, certain drugs, vibration.
  • Typical signs: triphasic color change (white, blue, red), numbness, pain.
  • When to seek care: persistent color change, pain, or skin breakdown that suggests ischemia.